Published in Nucleic Acids Res on October 31, 2012
HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc (2003) 11.65
Crystal structure of trp repressor/operator complex at atomic resolution. Nature (1988) 7.34
Crystal structure of a bacterial RNA polymerase holoenzyme at 2.6 A resolution. Nature (2002) 6.74
Crystal structure of an IHF-DNA complex: a protein-induced DNA U-turn. Cell (1996) 5.38
The HADDOCK web server for data-driven biomolecular docking. Nat Protoc (2010) 5.22
Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions. Nat Protoc (2007) 3.31
Polypeptides containing highly conserved regions of transcription initiation factor sigma 70 exhibit specificity of binding to promoter DNA. Cell (1992) 3.27
RNA polymerase-promoter interactions: the comings and goings of RNA polymerase. J Bacteriol (1998) 3.16
Crystal structure of a sigma 70 subunit fragment from E. coli RNA polymerase. Cell (1996) 2.90
Structural basis for promoter-10 element recognition by the bacterial RNA polymerase σ subunit. Cell (2011) 2.82
Analysis of the sequence-specific interactions between Cro repressor and operator DNA by systematic base substitution experiments. Proc Natl Acad Sci U S A (1989) 2.76
Genetic evidence for interaction of sigma A with two promoters in Bacillus subtilis. J Bacteriol (1991) 2.72
Lambda repressor recognizes the approximately 2-fold symmetric half-operator sequences asymmetrically. Proc Natl Acad Sci U S A (1989) 2.61
Fluorescence polarization analysis of protein-DNA and protein-protein interactions. Mol Endocrinol (1996) 2.36
Anatomy of Escherichia coli sigma70 promoters. Nucleic Acids Res (2006) 2.25
3D-DART: a DNA structure modelling server. Nucleic Acids Res (2009) 1.99
DNA sequence elements located immediately upstream of the -10 hexamer in Escherichia coli promoters: a systematic study. Nucleic Acids Res (2000) 1.79
Escherichia coli promoter opening and -10 recognition: mutational analysis of sigma70. EMBO J (2000) 1.71
DNA bending and wrapping around RNA polymerase: a "revolutionary" model describing transcriptional mechanisms. Microbiol Mol Biol Rev (1999) 1.70
Control of gal transcription through DNA looping: inhibition of the initial transcribing complex. Proc Natl Acad Sci U S A (1992) 1.65
The structural basis of DNA flexibility. Philos Trans A Math Phys Eng Sci (2004) 1.33
T7 RNA polymerase-induced bending of promoter DNA is coupled to DNA opening. Biochemistry (2006) 1.31
Three-dimensional EM structure of an intact activator-dependent transcription initiation complex. Proc Natl Acad Sci U S A (2009) 1.26
A "master" in base unpairing during isomerization of a promoter upon RNA polymerase binding. Proc Natl Acad Sci U S A (2001) 1.25
Nonintercalative DNA-binding antitumour compounds. Mol Cell Biochem (1982) 1.21
Evidence for a tyrosine-adenine stacking interaction and for a short-lived open intermediate subsequent to initial binding of Escherichia coli RNA polymerase to promoter DNA. J Mol Biol (2008) 1.17
Direct evidence for the preferential binding of Escherichia coli RNA polymerase holoenzyme to the ends of deoxyribonucleic acid restriction fragments. Biochemistry (1983) 1.11
The 0 degree C closed complexes between Escherichia coli RNA polymerase and two promoters, T7-A3 and lacUV5. J Biol Chem (1987) 1.09
Analysis of RNA polymerase-promoter complex formation. Methods (2008) 1.08
Temperature-dependence of open-complex formation at two Escherichia coli promoters with extended -10 sequences. Biochem J (1996) 1.05
Redefining Escherichia coli σ(70) promoter elements: -15 motif as a complement of the -10 motif. J Bacteriol (2011) 1.03
Strand opening-deficient Escherichia coli RNA polymerase facilitates investigation of closed complexes with promoter DNA: effects of DNA sequence and temperature. J Biol Chem (2007) 1.01
Indirect recognition in sequence-specific DNA binding by Escherichia coli integration host factor: the role of DNA deformation energy. J Biol Chem (2006) 0.98
GalR represses galP1 by inhibiting the rate-determining open complex formation through RNA polymerase contact: a GalR negative control mutant. J Mol Biol (2004) 0.98
A cognate tRNA specific conformational change in glutaminyl-tRNA synthetase and its implication for specificity. Protein Sci (1998) 0.85
Escherichia coli proteins eluted from mono Q chromatography, a final step during RNA polymerase purification procedure. Methods Enzymol (2003) 0.84
Dimer-dimer interfaces of the lambda-repressor are different in liganded and free states. Biochemistry (1996) 0.83
Specific inhibition of p300-HAT alters global gene expression and represses HIV replication. Chem Biol (2007) 2.15
X-ray studies of crystalline complexes involving amino acids and peptides. XLIII. Adipic acid complexes of L- and DL-lysine. Acta Crystallogr C (2006) 1.43
X-ray studies of crystalline complexes involving amino acids and peptides. XLIV. Invariant features of supramolecular association and chiral effects in the complexes of arginine and lysine with tartaric acid. Acta Crystallogr B (2007) 1.38
Molecular basis for H3K36me3 recognition by the Tudor domain of PHF1. Nat Struct Mol Biol (2012) 1.27
Structural plasticity and enzyme action: crystal structures of mycobacterium tuberculosis peptidyl-tRNA hydrolase. J Mol Biol (2007) 1.24
Natural products: promising resources for cancer drug discovery. Anticancer Agents Med Chem (2012) 1.23
Molecular basis of phosphatidylinositol 4-phosphate and ARF1 GTPase recognition by the FAPP1 pleckstrin homology (PH) domain. J Biol Chem (2011) 1.21
The MBT repeats of L3MBTL1 link SET8-mediated p53 methylation at lysine 382 to target gene repression. J Biol Chem (2010) 1.13
Prevalence and risk factors of asthma and wheeze in school-going children in Lucknow, North India. Indian Pediatr (2004) 1.05
Differential recognition of phosphorylated transactivation domains of p53 by different p300 domains. J Mol Biol (2007) 1.01
Kinetics of transcription initiation at lacP1. Multiple roles of cyclic AMP receptor protein. J Biol Chem (2003) 0.97
Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells. Biotechnol Prog (2008) 0.96
SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription. J Mol Biol (2009) 0.96
Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension. Am J Physiol Renal Physiol (2009) 0.95
Molecular mechanism of MLL PHD3 and RNA recognition by the Cyp33 RRM domain. J Mol Biol (2010) 0.94
Aib-based peptide backbone as scaffolds for helical peptide mimics. J Pept Res (2002) 0.94
Structural determinant of human La protein critical for internal initiation of translation of hepatitis C virus RNA. J Virol (2008) 0.93
DnaK-sigma 32 interaction is temperature-dependent. Implication for the mechanism of heat shock response. J Biol Chem (2002) 0.91
SMAR1 regulates free radical stress through modulation of AKR1a4 enzyme activity. Int J Biochem Cell Biol (2010) 0.89
Functional compensation of glutathione S-transferase M1 (GSTM1) null by another GST superfamily member, GSTM2. Sci Rep (2013) 0.88
Slow solvation dynamics at the active site of an enzyme: implications for catalysis. Biochemistry (2005) 0.88
Cellular and molecular mechanisms of cigarette smoke-induced lung damage and prevention by vitamin C. J Inflamm (Lond) (2008) 0.86
Role of C-terminal residues in oligomerization and stability of lambda CII: implications for lysis-lysogeny decision of the phage. J Mol Biol (2005) 0.86
Exploration of a binding mode of benzothiazol-2-yl acetonitrile pyrimidine core based derivatives as potent c-Jun N-terminal kinase-3 inhibitors and 3D-QSAR analyses. J Chem Inf Model (2006) 0.85
Specific small-molecule activator of Aurora kinase A induces autophosphorylation in a cell-free system. J Med Chem (2008) 0.85
The zinc-binding site of a class I aminoacyl-tRNA synthetase is a SWIM domain that modulates amino acid binding via the tRNA acceptor arm. Eur J Biochem (2004) 0.85
Effect of phosphorylation on the structure and fold of transactivation domain of p53. J Biol Chem (2002) 0.85
Exploring the structure of opioid receptors with homology modeling based on single and multiple templates and subsequent docking: a comparative study. J Mol Model (2010) 0.83
Glutamate counteracts the denaturing effect of urea through its effect on the denatured state. J Biol Chem (2003) 0.83
P-protein of Chandipura virus is an N-protein-specific chaperone that acts at the nucleation stage. Biochemistry (2004) 0.83
Rationalizing fragment based drug discovery for BACE1: insights from FB-QSAR, FB-QSSR, multi objective (MO-QSPR) and MIF studies. J Comput Aided Mol Des (2010) 0.81
A chimaeric glutamyl:glutaminyl-tRNA synthetase: implications for evolution. Biochem J (2009) 0.81
Monomer and dimer of Chandipura virus unphosphorylated P-protein binds leader RNA differently: implications for viral RNA synthesis. J Mol Biol (2004) 0.81
A functional loop spanning distant domains of glutaminyl-tRNA synthetase also stabilizes a molten globule state. Biochemistry (2012) 0.81
Small cationic protein from a marine turtle has beta-defensin-like fold and antibacterial and antiviral activity. Proteins (2006) 0.81
Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation. Proc Natl Acad Sci U S A (2014) 0.81
The role of the catalytic domain of E. coli GluRS in tRNAGln discrimination. FEBS Lett (2009) 0.81
Antagonists of Hsp16.3, a low-molecular-weight mycobacterial chaperone and virulence factor, derived from phage-displayed peptide libraries. Appl Environ Microbiol (2005) 0.80
Cysteine-3 and cysteine-4 are essential for the thioredoxin-like oxidoreductase and antioxidant activities of Plasmodium falciparum macrophage migration inhibitory factor. Free Radic Biol Med (2011) 0.80
Solvation dynamics of a protein in the pre molten globule state. J Phys Chem B (2006) 0.80
Specific sequence of a Beta turn in human la protein may contribute to species specificity of hepatitis C virus. J Virol (2014) 0.80
Disorder-order transition of lambda CII promoted by low concentrations of guanidine hydrochloride suggests a stable core and a flexible C-terminus. Eur J Biochem (2003) 0.79
Peptide-protein interactions suggest that acetylation of lysines 381 and 382 of p53 is important for positive coactivator 4-p53 interaction. J Biol Chem (2011) 0.79
Probing the structure of Leishmania donovani chagasi DHFR-TS: comparative protein modeling and protein-ligand interaction studies. J Mol Model (2010) 0.79
Cloning, expression, purification, crystallization and preliminary X-ray analysis of peptidyl-tRNA hydrolase from Mycobacterium tuberculosis. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.79
Why pyridine containing pyrido[2,3-d]pyrimidin-7-ones selectively inhibit CDK4 than CDK2: insights from molecular dynamics simulation. J Mol Graph Model (2010) 0.79
Combinatorial library enumeration and lead hopping using comparative interaction fingerprint analysis and classical 2D QSAR methods for seeking novel GABA(A) alpha(3) modulators. J Chem Inf Model (2009) 0.79
Half-of-the-sites reactivity of F235C lambda-repressor: implications for the structure of the whole repressor. Protein Eng (2002) 0.79
Combined ligand and structure based approaches for narrowing on the essential physicochemical characteristics for CDK4 inhibition. J Chem Inf Model (2008) 0.79
Retracted A computational docking study for prediction of binding mode of diospyrin and derivatives: Inhibitors of human and leishmanial DNA topoisomerase-I. Bioorg Med Chem Lett (2007) 0.78
14-Deoxyandrographolide targets adenylate cyclase and prevents ethanol-induced liver injury through constitutive NOS dependent reduced redox signaling in rats. Food Chem Toxicol (2013) 0.78
Deciphering ligand dependent degree of binding site closure and its implication in inhibitor design: A modeling study on human adenosine kinase. J Mol Graph Model (2009) 0.78
In silico quest for putative drug targets in Helicobacter pylori HPAG1: molecular modeling of candidate enzymes from lipopolysaccharide biosynthesis pathway. J Mol Model (2011) 0.78
An efficient tool for identifying inhibitors based on 3D-QSAR and docking using feature-shape pharmacophore of biologically active conformation--a case study with CDK2/cyclinA. Eur J Med Chem (2007) 0.78
Structural basis for ligand recognition at the benzodiazepine binding site of GABAA alpha 3 receptor, and pharmacophore-based virtual screening approach. J Mol Graph Model (2008) 0.78
A synthetic peptide mimic of λ-Cro shows sequence-specific binding in vitro and in vivo. ACS Chem Biol (2012) 0.78
Evaluation of anti-diabetic and alpha glucosidase inhibitory action of anthraquinones from Rheum emodi. Food Funct (2015) 0.77
Hybrid structure-based virtual screening protocol for the identification of novel BACE1 inhibitors. J Chem Inf Model (2009) 0.77
Human placental extract mediated inhibition of proteinase K: implications of heparin and glycoproteins in wound physiology. J Cell Physiol (2014) 0.77
3D-QSAR studies and shape based virtual screening for identification of novel hits to inhibit MbtA in Mycobacterium tuberculosis. J Biomol Struct Dyn (2014) 0.77
A cyclic peptide mimic of an RNA recognition motif of human La protein is a potent inhibitor of hepatitis C virus. Antiviral Res (2013) 0.77
Structural features of human histone acetyltransferase p300 and its complex with p53. FEBS Lett (2012) 0.77
Discovery of safe and orally effective 4-aminoquinaldine analogues as apoptotic inducers with activity against experimental visceral leishmaniasis. Antimicrob Agents Chemother (2011) 0.77
High-affinity quasi-specific sites in the genome: how the DNA-binding proteins cope with them. Biophys J (2011) 0.77
Conformational adaptation in the E. coli sigma 32 protein in response to heat shock. J Phys Chem B (2014) 0.76
Recognition of different DNA sequences by a DNA-binding protein alters protein dynamics differentially. FEBS Lett (2012) 0.76
Deciphering the binding mode of Zolpidem to GABA(A) α₁ receptor - insights from molecular dynamics simulation. J Mol Model (2011) 0.76
Probing the structure of Mycobacterium tuberculosis MbtA: model validation using molecular dynamics simulations and docking studies. J Biomol Struct Dyn (2013) 0.76
Target specific proteochemometric model development for BACE1 - protein flexibility and structural water are critical in virtual screening. Mol Biosyst (2015) 0.76
Binding of the iminium and alkanolamine forms of sanguinarine to lysozyme: spectroscopic analysis, thermodynamics, and molecular modeling studies. J Phys Chem B (2014) 0.76
Simultaneous inhibition of key growth pathways in melanoma cells and tumor regression by a designed bidentate constrained helical peptide. Biopolymers (2014) 0.76
In silico work flow for scaffold hopping in Leishmania. BMC Res Notes (2014) 0.75
Switching DNA-binding specificity by unnatural amino acid substitution. Nucleic Acids Res (2005) 0.75
Modeling the closed and open state conformations of the GABA(A) ion channel--plausible structural insights for channel gating. J Chem Inf Model (2012) 0.75
A genetic network that balances two outcomes utilizes asymmetric recognition of operator sites. Biophys J (2012) 0.75
Solvation change and ion release during aminoacylation by aminoacyl-tRNA synthetases. Nucleic Acids Res (2003) 0.75
Conformational selection underpins recognition of multiple DNA sequences by proteins and consequent functional actions. Phys Chem Chem Phys (2016) 0.75
Ligand specificity and ligand-induced conformational change in gal repressor. Proteins (2002) 0.75
A peptide targeted against phosphoprotein and leader RNA interaction inhibits growth of Chandipura virus -- an emerging rhabdovirus. Antiviral Res (2013) 0.75
Rationalizing lead optimization by consensus 2D- CoMFA CoMSIA GRIND (3D) QSAR guided fragment hopping in search of γ-secretase inhibitors. Mol Divers (2012) 0.75
Alternative sigma factors in the free state are equilibrium mixtures of open and compact conformations. Biochemistry (2010) 0.75
International symposium on challenges in chemical biology: toward the formation of Chemical Biology Society of India. ACS Chem Biol (2013) 0.75
X-ray studies on crystalline complexes involving amino acids and peptides. XLI. Commonalities in aggregation and conformation revealed by the crystal structures of the pimelic acid complexes of L-arginine and DL-lysine. Acta Crystallogr B (2003) 0.75
Molecular Simulations of Mixed Lipid Bilayers with Sphingomyelin, Glycerophospholipids and Cholesterol. J Phys Chem B (2017) 0.75
Chelerythrine-lysozyme interaction: spectroscopic studies, thermodynamics and molecular modeling exploration. Phys Chem Chem Phys (2015) 0.75
Optimal design of metabolic flux analysis experiments for anchorage-dependent mammalian cells using a cellular automaton model. Biotechnol Bioeng (2007) 0.75
Chemical biology research in India. ACS Chem Biol (2011) 0.75
Ultrafast differential flexibility of Cro-protein binding domains of two operator DNAs with different sequences. Phys Chem Chem Phys (2016) 0.75